A retrospective case-control study evaluating efficacy of citicoline plus rivastigmine in patients with in Alzheimer's disease and mixed dementia.

Trial Profile

A retrospective case-control study evaluating efficacy of citicoline plus rivastigmine in patients with in Alzheimer's disease and mixed dementia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Oct 2016

At a glance

  • Drugs Citicoline (Primary) ; Rivastigmine (Primary)
  • Indications Alzheimer's disease; Dementia
  • Focus Therapeutic Use
  • Acronyms CITIRIVAD
  • Most Recent Events

    • 21 Oct 2016 New trial record
    • 01 Sep 2016 Results published in the Clinical Drug Investigation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top